These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 19221279)
21. Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy. Fujii K; Usuki A; Kan-No Y; Ohgou N J Dermatol; 2008 May; 35(5):308-10. PubMed ID: 18477235 [No Abstract] [Full Text] [Related]
22. The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma). Lee P; Norman CS; Sukenik S; Alderdice CA J Rheumatol; 1985 Jun; 12(3):514-7. PubMed ID: 2931522 [TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor and coagulopathy in patients with prostate cancer. Nakashima J; Tachibana M; Ueno M; Baba S; Tazaki H Cancer Res; 1995 Nov; 55(21):4881-5. PubMed ID: 7585524 [TBL] [Abstract][Full Text] [Related]
24. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens. Song KS; Kim YA; Kim HK; Park Q Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712 [TBL] [Abstract][Full Text] [Related]
25. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia]. Zhuang Q; Zeng Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038 [TBL] [Abstract][Full Text] [Related]
26. Serum Concentrations of Angiopoietin-2 and Soluble fms-Like Tyrosine Kinase 1 (sFlt-1) Are Associated with Coagulopathy among Patients with Acute Pancreatitis. Dumnicka P; Kuśnierz-Cabala B; Sporek M; Mazur-Laskowska M; Gil K; Kuźniewski M; Ceranowicz P; Warzecha Z; Dembiński A; Bonior J; Drożdż R Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368336 [TBL] [Abstract][Full Text] [Related]
27. Coagulation biomarkers in critically ill patients. Levi M; Schultz M; van der Poll T Crit Care Clin; 2011 Apr; 27(2):281-97. PubMed ID: 21440202 [TBL] [Abstract][Full Text] [Related]
29. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen]. Soria J; Soria C Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099 [No Abstract] [Full Text] [Related]
31. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis]. Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330 [TBL] [Abstract][Full Text] [Related]
32. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules. Matsuda M; Baba M; Morimoto K; Nakamikawa C J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002 [TBL] [Abstract][Full Text] [Related]
33. [Fibrin degradation products (FDP) and fibrinolytic activity of blood in various acute and chronic diseases]. Kotschy M Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):425-30. PubMed ID: 63429 [No Abstract] [Full Text] [Related]
34. Proceedings: Structural abnormality in the gamma polypeptide chain of Paris I fibrinogen. Budzynski AZ; Marder VJ; Ménaché D; Guillin MC Thromb Diath Haemorrh; 1975 Sep; 34(1):329. PubMed ID: 1188747 [No Abstract] [Full Text] [Related]
35. [Plasma D-dimer changes in chronic severe hepatitis B patients]. Yin YM; Liu AP; Geng AW; Zhang Y Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):59-60. PubMed ID: 21272463 [No Abstract] [Full Text] [Related]
36. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis. Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386 [TBL] [Abstract][Full Text] [Related]
37. [Simultaneous quantification of soluble fibrin and D-dimer in blood plasma for the assessment of the threat of thrombosis]. Lugovskii EV; Kolesnikova IN; Platonova TN; Lugovskaia NE; Litvinova LM; Kostiuchenko EP; Chernyshenko TM; Ganova LA; Spivak NIa; Komisarenko SV Klin Med (Mosk); 2013; 91(11):38-44. PubMed ID: 25696964 [TBL] [Abstract][Full Text] [Related]
38. [The clinical significance of D-dimer in systemic lupus erythematosus]. Li C; Mu R; Ren LM; Fan WQ; Ren CJ; Li ZG Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1039-42. PubMed ID: 21211364 [TBL] [Abstract][Full Text] [Related]